AIM: To estimate radiation doses deriving from patients treated with 166Ho ferric hydroxide. METHODS: For radiation synoviorthesis about 900 100 MBq 166Ho ferric hydroxide was injected into the knee joint of 16 patients...
Keywords: 166 Ho, Radiosynoviorthese, Strahlenexposition, Strahlen-schutz
01/2003 | Nuklearmedizin, SchattauerAIM: The radiation exposure in radiation synovectomy was investigated for technician and therapist using Erbium-169, Rhenium-186 and Yttrium-90 with and without syringe shieldings. METHODS: Dose rates were measured in relation to the distance of the syringe containing the radionuclide...
Keywords: Spritzenabschirmung, Radiosynoviorthese, Strahlen-exposition, Betastrahler, Erbium-169, Rhenium-186, Yttrium-90
01/2003 | Nuklearmedizin, SchattauerAim: A pilote study for estimation of radiation exposure due to diagnostic procedures in nuclear medicine using routine data of hospitals and practices in Germany. Methods: Hospitals and practices willing to participate in the study supplied data of one year (1997), containing information on patients' identification number, age, sex, type of diagnostic procedure, radiopharmaceutical, administered activity, type of health insurance (private/public), inpatient/outpatient status, and so-called Leistungsziffer, which describes the type of medical performances in Germany...
Keywords: Strahlenexposition, effektive Dosis, Nuklearmedizin
01/2004 | Nuklearmedizin, SchattauerDiagnostic reference levels (DRL) were introduced in Germany by a publication in the Bundesanzeiger Nr...
Keywords: Nuklearmedizinische Diagnostik, Strahlenexposition, interne Dosismetrie, diagnostische Referenzwerte
01/2004 | Nuklearmedizin, SchattauerThe aim of this study was to estimate both the frequency and effective dose of nuclear medicine procedures performed in Germany between 1996 and 2000 for different subgroups of patients...
Keywords: Strahlenbelastung, Applikationen, Radiopharmaka, effektive Dosis
01/2005 | Nuklearmedizin, SchattauerAim of this study was the assessment of the radiation exposure from preparation and application of 90Y-Zevalin, the measurement of the dose rate at the patient, the exposure of family members as well as the determination of the activity concentration in urine of patients...
Keywords: Ibritumomab Tiuxetan, Zevalin, 90Y, ß - -Strahlung, Bremsstrahlung, Radioimmuntherapie, Strahlenexposition, Hautdosis, Strahlenschutz
01/2006 | Nuklearmedizin, Schattauer